Hepatitis: all 3,372 studies

Page 18 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.

• Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
• Long Term Follow-up of Hepatitis C Cured PatientsCompletedNCT03246048
• Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1CompletedNCT03245931
• A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B PatientsStatus unknownNCT03244085Phase 1
• Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.Status unknownNCT03241823
• Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.CompletedNCT03241641Phase 4
• Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot StudyCompletedNCT03231930Not applicable
• Comparative Immunogenicity Study of Two Hepatitis A VaccinesStatus unknownNCT03231605Phase 4
• Effects of Direct Antiviral Agents on Hepatitis C Virus ArthropathyStatus unknownNCT03226717
• Transforming the Cascade Of Hepatitis C CareCompletedNCT03226509
• Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1bStatus unknownNCT03222167Phase 3
• Impact of Hepatitis C Therapy and Bone HealthTerminatedNCT03221582Phase 4
• Study of AT-527 in Healthy and HCV-Infected SubjectsCompletedNCT03219957Phase 1
• Immunologic Response of Hepatitis B VaccineStatus unknownNCT03219203Phase 4
• Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, SenegalCompletedNCT03215732
• The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
• Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus InfectionStatus unknownNCT03212833
• The Changes of Cytokines During Antiviral TherapyStatus unknownNCT03210506Not applicable
• The Changes of Treg Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210493Not applicable
• The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210467
• The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal TimeStatus unknownNCT03209908
• The Changes of CD8+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209037Phase 4
• The Changes of CD4+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209011Phase 4
• The Changes of Natural Killer Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03208998Phase 4
• Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in AdultsWithdrawnNCT03208322
• A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New DrugsCompletedNCT03201718
• Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 PatientsCompletedNCT03200184Phase 4
• Effect of DAAs on Behavior of HCC in HCV PatientsCompletedNCT03200171
• Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRICompletedNCT03198104
• Direct-acting Antivirals and Hepatocellular Carcinoma RecurrenceCompletedNCT03197155
• The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsCompletedNCT03188276Early Phase 1
• 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild FibrosisCompletedNCT03186365Phase 3
• T Regulatory Cells in Hepatitis c Infected PatientsCompletedNCT03186235
• Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in IsraelWithdrawnNCT03183492Phase 4
• Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa TherapyCompletedNCT03181113
• Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in AdultsCompletedNCT03181074
• The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03180333Phase 1
• The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03173599Phase 1
• Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral DrugsStatus unknownNCT03170076
• The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related ThrombocytopeniaStatus unknownNCT03169348Not applicable
• A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)CompletedNCT03168412Phase 4
• the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac FunctionStatus unknownNCT03166943Not applicable
• Hepatitis c and Vitamin D and Iron StatusStatus unknownNCT03166280
• Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for NonadherenceStatus unknownNCT03164902Not applicable
• Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B PatientsTerminatedNCT03164889Not applicable
• Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus PatientsStatus unknownNCT03163849Phase 3
• Corticosteroids in Alcoholic HepatitisStatus unknownNCT03160651Not applicable
• Hepatitis C Treatment Study in MyanmarWithdrawnNCT03158857
• The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.CompletedNCT03157388Not applicable
• Optimizing HBV Management During Anti-CD20 AntibodiesCompletedNCT03155984
• Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis PatientsCompletedNCT03149874Not applicable
• Hepatitis C Virus Infection in Patients With HemoglobinopathiesCompletedNCT03149289
• Direct Acting Agents in Hepatitis C PatientsCompletedNCT03145844
• Real World Experience of Chronic Hepatitis C (CHC) Treatment in IsraelCompletedNCT03144440
• Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)WithdrawnNCT03143998Phase 4
• A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B SubjectsWithdrawnNCT03125213Phase 2
• To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.Status unknownNCT03123653Not applicable
• Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 WeeksCompletedNCT03122132
• TAF for HIV-HBV With Renal DysfunctionCompletedNCT03115736Phase 2
• "Treatment of Active HBV With γδT Cells" Clinical Trial ProtocolStatus unknownNCT03113058Early Phase 1
• Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World CohortCompletedNCT03111966
• Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis BCompletedNCT03109730Phase 1/2
• Hepatitis C Virus Detection in Oral Squamous Cell CarcinomaCompletedNCT03109457
• Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis DStatus unknownNCT03105310Phase 2
• Ezetimibe for Patients With Chronic Hepatitis DStatus unknownNCT03099278Phase 2
• A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) InfectionTerminatedNCT03099135Phase 3
• A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.Status unknownNCT03091010Not applicable
• Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C TreatmentCompletedNCT03090035Phase 3
• Pilot Study of HIV and Hepatitis B and C Screening in SurgeryCompletedNCT03088995
• Transplanting Hepatitis C Positive OrgansStatus unknownNCT03086044Phase 4
• The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCCStatus unknownNCT03084250Phase 4
• Immunity to Hepatitis B VaccineCompletedNCT03083158Phase 4
• Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & DaclatasvirCompletedNCT03080415Phase 3
• Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio TherapyCompletedNCT03071133
• Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsStatus unknownNCT03067883Phase 2
• Treating Hepatitis C in CRF Using Sofosbuvir and DaclatasvirCompletedNCT03063879Phase 4
• Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAsCompletedNCT03063723
• Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)Status unknownNCT03062813Phase 4
• Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian PatientsStatus unknownNCT03061032Phase 3
• Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy PatientsCompletedNCT03057236Not applicable
• Off-therapy Response After Stopping Entecavir or TenofovirStatus unknownNCT03042481
• Vertical Transmission of Hepatitis C in Adult Children of Female Baby BoomersCompletedNCT03038763
• Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label TrialCompletedNCT03032666Phase 4
• Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
• Orange Juice Consumption in Patients With Hepatitis CCompletedNCT03026569Not applicable
• Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac TransplantWithdrawnNCT03026023Phase 4
• Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis CStatus unknownNCT03022006Phase 4
• The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis BStatus unknownNCT03018821Not applicable
• Curing HCV in Incarcerated PatientsStatus unknownNCT03018353Phase 4
• Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B PatientsStatus unknownNCT03013556Phase 4
• Anticipated and Perceived Benefits Following Hepatitis C TreatmentCompletedNCT03000023
• Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIHActive, not recruitingNCT02997878Phase 1/2
• Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B VirusCompletedNCT02995005Phase 1/2
• Study of the Clinical Features of Autoimmune HepatitisStatus unknownNCT02994537
• Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C InfectionCompletedNCT02992457Phase 4
• Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
• Hepatitis C Infection in World Trade Center RespondersCompletedNCT02982993
• To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis BStatus unknownNCT02982837Phase 4
• REALM China Extension StudyStatus unknownNCT02974829
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4

← Hepatitis overview